177 related articles for article (PubMed ID: 2570706)
1. [3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors.
Langin D; Lafontan M; Stillings MR; Paris H
Eur J Pharmacol; 1989 Aug; 167(1):95-104. PubMed ID: 2570706
[TBL] [Abstract][Full Text] [Related]
2. New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
Galitzky J; Larrouy D; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1990 Jan; 252(1):312-9. PubMed ID: 1967647
[TBL] [Abstract][Full Text] [Related]
3. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
[TBL] [Abstract][Full Text] [Related]
4. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
Mallard NJ; Hudson AL; Nutt DJ
Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
[TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
Langin D; Paris H; Lafontan M
Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Wallace DR; Muskardin DT; Zahniser NR
Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
[TBL] [Abstract][Full Text] [Related]
7. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
8. Identification of alpha 2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells.
Senard JM; Langin D; Estan L; Paris H
Eur J Pharmacol; 1990 Nov; 191(1):59-68. PubMed ID: 1982658
[TBL] [Abstract][Full Text] [Related]
9. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
Remaury A; Paris H
J Pharmacol Exp Ther; 1992 Jan; 260(1):417-26. PubMed ID: 1346166
[TBL] [Abstract][Full Text] [Related]
10. Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells.
Langin D; Paris H; Dauzats M; Lafontan M
Eur J Pharmacol; 1990 Apr; 188(4-5):261-72. PubMed ID: 1973120
[TBL] [Abstract][Full Text] [Related]
11. Alpha-2 adrenoceptor in rat jejunum epithelial cells: characterization with [3H]RX821002 and distribution along the villus-crypt axis.
Paris H; Voisin T; Remaury A; Rouyer-Fessard C; Daviaud D; Langin D; Laburthe M
J Pharmacol Exp Ther; 1990 Sep; 254(3):888-93. PubMed ID: 1975626
[TBL] [Abstract][Full Text] [Related]
12. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
13. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human alpha 2-adrenoceptor subtypes: comparison of [3H]rauwolscine, [3H]atipamezole and [3H]RX821002 as radioligands.
Halme M; Sjöholm B; Savola JM; Scheinin M
Biochim Biophys Acta; 1995 Apr; 1266(2):207-14. PubMed ID: 7742388
[TBL] [Abstract][Full Text] [Related]
15. [3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes.
Langin D; Lafontan M
Eur J Pharmacol; 1989 Jan; 159(2):199-203. PubMed ID: 2565242
[TBL] [Abstract][Full Text] [Related]
16. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
17. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
O'Rourke MF; Blaxall HS; Iversen LJ; Bylund DB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1362-7. PubMed ID: 7908054
[TBL] [Abstract][Full Text] [Related]
18. Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding.
Uhlén S; Wikberg JE
Pharmacol Toxicol; 1991 Nov; 69(5):341-50. PubMed ID: 1687079
[TBL] [Abstract][Full Text] [Related]
19. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
Boyajian CL; Leslie FM
J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
